Sign inJoin waitlistJoin the waitlist

Susanne Cabrera

Professor · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · · ·

History

Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Children's Wisconsin - Fox Valley
Present
Children's Wisconsin - Fox Valley
Present

Pediatric Endocrinology
Indiana University School of Medicine
2012–2015
Endocrinology, Diabetes, and Metabolism
Indiana University School of Medicine
2010–2012
Internal Medicine-Pediatrics
Indiana University School of Medicine
2005–2009
University of Tennessee College of Medicine
2001–2005

Research

Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model
Diabetes · 2012 · 309 citations
Age of thelarche and menarche in contemporary US females: a cross-sectional analysis
Journal of Pediatric Endocrinology and Metabolism · 2014 · First of 5 authors · 72 citations
Innate inflammation in type 1 diabetes
Review · Translational research · 2016 · First of 3 authors · 66 citations

Linda DiMeglio
4 papers
Raghavendra Mirmira
4 papers
CG
Carla Greenbaum
3 papers
Carmella Evans-Molina
2 papers · 1 as a fellow
Erica Eugster
2 papers
Abby Cobb-Walch
1 paper · 1 as a fellow
AK
Abhishek Kulkarni
1 paper
Alan Rogol
1 paper
Alejandro Siller
1 paper
Alicia Diaz-Thomas
1 paper
Alison Coren
1 paper
Ananta Addala
1 paper

Grants

Reducing Innate Inflammation in New Onset T1D with Lactobacillus Plantarum
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.8M · Medical College of Wisconsin
2020–2026
Cardiometabolic Impact of Gender-Affirming Hormone Therapy in Transmasculine Young Adults
National Heart, Lung, and Blood Institute · R01
PI · $779.8K · Medical College of Wisconsin
2025

Clinical trials

Development of Predictive Biomarkers
Principal investigator · Completed
Medical College of Wisconsin
2017–2021
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Site PI · Not yet recruiting
Medical College of Wisconsin
2026–2029
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2027